Hierrodexina solution for injection

البلد: أرمينيا

اللغة: الإنجليزية

المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

العنصر النشط:

iron polysaccharide, cobalt chloride, vitamin B12

متاح من:

Invesa Industrial Veterinaria

ATC رمز:

Կիրառելի չէ (QB03AC)

INN (الاسم الدولي):

iron polysaccharide, cobalt chloride, vitamin B12

جرعة:

100mg/ml+ 4mcg/ml+ 25mcg/ml

الشكل الصيدلاني:

solution for injection

الوحدات في الحزمة:

50ml and 100ml glass vial

نوع الوصفة الطبية :

Prescription

الوضع إذن:

Registered

تاريخ الترخيص:

2020-03-11

خصائص المنتج

HIERRODEXINA Injectable solution
SUMMARY OF PRODUCT CHARACTERISTICS (SPC)
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
HIERRODEXINA
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substances:
Iron (as iron dextran)
100 mg
Cobalt chloride
4

g
Vitamin B
12
25

g
Excipients:
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Solution for injection
4. CLINICAL PARTICULARS
4.1. TARGET SPECIES
Swine, Cattle and Sheep.
4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
- SWINE, CATTLE AND SHEEP
Treatment of hypochromic type anemia caused by iron deficiency,
especially
anemia
of
piglets.
It
is
used
to
increase
resistance
to
microbial
diseases
(pneumonia, diarrhea,...) during pregnancy, in periods of
convalescence, in cattle
piroplasmosis and in general as a tonic.
HIERRODEXINA Injectable solution
4.3. CONTRAINDICATIONS
Not described.
4.4. SPECIAL WARNINGS
If the injection is administered into the semitendinosus or
semimembranosus
muscles can cause injuries to the tibial and peroneal nerve, with
subsequent
loss of muscle tone.
4.5. SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Disinfect injection site prior to administration.
SPECIAL
PRECAUTIONS
TO
BE
TAKEN
BY
THE
PERSON
ADMINISTERING
THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of self-injection or ingestion seek medical advice immediately
and show
the package leaflet or the label to the physician.
In case of contact with skin or eyes, wash with water.
4.6. ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Coloration at the injection site.
Local reaction may occur as inflammation at the injection site, edema
and
necrosis.
4.7. USE DURING PREGNANCY, LACTATION OR LAY
No contraindications have been reported during these periods.
4.8.
INTERACTION
WITH
OTHER
MEDICINAL
PRODUCTS
AND
OTHER
FORMS
OF
INTERACTION
Do not administer simultaneously with oral iron preparations.
HIERRODEXINA Injectable solution
4.9. AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Deep intramuscular route.
-Piglets:
Prophylaxi